Royalty Pharma plc - Class A —— 财务报表 (NASDAQ:RPRX) | MetaTrader

展开完整图表

新闻

Can Royalty Pharma (RPRX) Keep the Earnings Surprise Streak Alive?

Revolution Medicines: PDAC Data Wows Wall Street - Jury's Out On Further Upside (RVMD)

Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings

Why Is Mirum Pharmaceuticals (MIRM) Down 3.6% Since Last Earnings Report?

Why Is Apellis Pharmaceuticals (APLS) Down 17.3% Since Last Earnings Report?

Why Is ImmunityBio (IBRX) Down 35.8% Since Last Earnings Report?

Defense Lifts Moat Stocks As Tech Stumbles

Royalty Pharma在TD Cowen会议上展示战略增长洞察

Royalty Pharma at TD Cowen Conference: Strategic Growth Insights

Citizens重申Zymeworks股票评级,基于强劲现金状况

Citizens reiterates Zymeworks stock rating on strong cash position

Zymeworks 2025年业绩显示Ziihera势头强劲推动营收增长176%